Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
Cédric Poyet(University of Zurich), Peter J. Wild(Goethe University Frankfurt), Tullio Sulser(University Hospital of Zurich), Ellen C. Zwarthoff(Erasmus MC), Qing Zhong(Guangxi Medical University), Arndt Hartmann(Universitätsklinikum Erlangen), Thomas Hermanns(University of Cologne), Daniel Eberli(University Hospital of Zurich), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ferdinand Hofstaedter(University of Regensburg), Maximilian Burger(University of Regensburg), Eva Drescher(University Hospital of Zurich)
Cited by 17
Related Papers
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381